Cognitive Disorders
40
4
5
26
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 40 trials
100.0%
+13.5% vs benchmark
10%
4 trials in Phase 3/4
15%
4 of 26 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 26 completed trials
Clinical Trials (40)
Dietary Strategy to Tackle Cognitive and Locomotor Abilities in Early Elderly Subjects
Neuroinflammatory Biomarkers After General Anesthesia: A Comparison Study
Breast Cancer and Chemobrain : Effects of Photobiomodulation on the Improvement of Perceived Cognitive Impairment
Post-stroke Cognitive Impairment and Dementia
Cognitive Functions in Severe Acquired Brain Injury After Cranioplasty
Single-center Prospective Longitudinal Study of Taste in Patients With Cognitive Disorders at Different Stages of Severity (Isolated Cognitive Complaint, Minor or Major Neurocognitive Alzheimer-type Disorders) by Analysis of Gustatory Evoked Potentials
Impact of a Standardized Equine Mediation Program on the Evolution of the Psycho-behavioral Profile of Adults With Traumatic Brain Injuries Experiencing Impaired Quality of Life (EPONA).
Cognitive Rehabilitation of Deficits in Patients With Multiple Sclerosis
The Effect of Physical Activity Level Evaluated by Wrist-wearable Devices on Cardiovascular Disease Risk and Other Outcomes in Peritoneal Dialysis Patients
Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Cognitive Disorders
Remote Cognitive Multidomain Assessment in People With Cognitive Disorders
Prospective Monocentric Study of Taste in Patients With Minor or Major Cognitive Disorders Such as Alzheimer's, Through the Analysis of Gustatory Evoked Potentials.
Evaluation of Cognitive and Motor Neurological Disorders in the Short and Long Term After Surgery for the Removal of a Diffuse Low-grade Glioma of the Supplementary Motor Area
A Single Ascending Oral Dose Study of SDI-118 in Healthy Male Subjects Including an Assessment of Receptor Occupancy and Food Effect
The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction
Cognitive Recovery After Electroconvulsive Therapy and General Anesthesia
Ramelteon in the Prevention of Post-operative Delirium
EGb 761® (Tanakan®) Effectiveness in the Treatment of Patients of Middle Age and Younger With Psycho-emotional Symptoms, Added to Cognitive Disorders
Anesthetic Depth and Postoperative Delirium Trial - 2
Spanish Adaptation and Validation of the Everyday Cognition Battery (ECB).